Table 50: Rest of Europe Historic Review for
Radiopharmaceuticals by Product Segment - Diagnostic
Radiopharmaceuticals and Therapeutic Radiopharmaceuticals
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2005 (includes corresponding
Graph/Chart) II-57
Table 51: Rest of Europe 10-Year Perspective for
Radiopharmaceuticals by Product Segment - Percentage
Breakdown of Value Sales for Diagnostic Radiopharmaceuticals
and Therapeutic Radiopharmaceuticals for Years 2006, 2009 &
2015 II-57
4. Research & Development Breakthroughs II-58
Azaya, Texas University Collaborate for Liposomal Radiation
Therapy II-58
Pharmacyclics Reveals Phase 1/2 Study of MGd Antibody Targeted
Radiation Therapy II-58
Peregrine Explores Potential of Cotara(R) for Brain Cancer
Treatment II-58
Scientists Develop New Manufacturing Technology For Cancer
Diagnostic Radioisotopes II-58
Avid Radiopharmaceuticals Exploits ExpIND to Speed AD Drug
Research II-59
Scientists Commend Combination Therapy for Follicular Lymphoma
Patients II-59
Missouri University Develops New Cancer Radiotherapy Method II-60
AGH Researchers Develop New Radioactive Seed Therapy for Lung
Cancer II-60
AnazaoHealth(R) Obtains US Patent for Novel Radiopharmaceutical
Preparations II-60
INMAS Develops Ciprofloxacin Radiolabelling Kit II-60
5. Product Innovations/Introductions II-61
Medrad Mounts Intego(TM) PET Infusion System at UPMC II-61
IBA Molecular Announces the Launch of Cyclone (R) 18 Twin II-61
Immunomedics Announces Pre-Clinical Results for its
Combination Radioimmunotherapy II-61
Molecular Insight Develops New Radi
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |